Shareholders' equity · 2011–2025

Catalyst Pharmaceuticals shareholders' equity

$954M+31.1% · FY2025

Catalyst Pharmaceuticals (CPRX) reported $954M in shareholders' equity for fiscal 2025, +31.1% year on year.

$3.8M2011$14.6M2012$21.4M2013$35.2M2014$55.5M2015$39.3M2016$81.0M2017$50.8M2018$87.6M2019$170M2020$207M2021$300M2022$388M2023$728M2024$954M2025
Catalyst Pharmaceuticals — Shareholders' equity, 2011–2025
Fiscal yearShareholders' equityChangeFiling
FY20252025-12-31$954M+31.1%Open →
FY20242024-12-31$728M+87.6%Open →
FY20232023-12-31$388M+29.1%Open →
FY20222022-12-31$300M+45.2%Open →
FY20212021-12-31$207M+22.0%Open →
FY20202020-12-31$170M+93.5%Open →
FY20192019-12-31$87.6M+72.6%Open →
FY20182018-12-31$50.8M−37.3%Open →
FY20172017-12-31$81.0M+106.0%Open →
FY20162016-12-31$39.3M−29.1%Open →
FY20152015-12-31$55.5M+57.4%Open →
FY20142014-12-31$35.2M+64.8%Open →
FY20132013-12-31$21.4M+46.3%Open →
FY20122012-12-31$14.6M+288.8%Open →
FY20112011-12-31$3.8M—Open →

Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +48.5%

Shareholders' equity at companies of similar size

Full ranking by shareholders' equity →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Catalyst Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/catalyst-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Catalyst Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/catalyst-pharmaceuticals/shareholders-equity

BibTeX

@misc{companiesranked-en-company-catalyst-pharmaceuticals-shareholders-equity-2026,
  author       = {{CompaniesRanked}},
  title        = {{Catalyst Pharmaceuticals shareholders' equity}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/catalyst-pharmaceuticals/shareholders-equity}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001369568-26-000002 · May 11, 2026

{{cite web |title=Catalyst Pharmaceuticals shareholders' equity — 10-Q (0001369568-26-000002) |url=https://www.sec.gov/Archives/edgar/data/1369568/000136956826000002/cprx-20260331.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-05-11}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Catalyst Pharmaceuticals overview